314 related articles for article (PubMed ID: 28220767)
21. Budesonide/formoterol maintenance and reliever therapy: a new treatment approach for adult patients with asthma.
Buhl R; Vogelmeier C
Curr Med Res Opin; 2007 Aug; 23(8):1867-78. PubMed ID: 17605896
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the effects of budesonide/formoterol maintenance and reliever therapy with fluticasone/salmeterol fixed-dose treatment on airway inflammation and small airway impairment in patients who need to step-up from inhaled corticosteroid monotherapy.
Hozawa S; Terada M; Hozawa M
Pulm Pharmacol Ther; 2014 Apr; 27(2):190-6. PubMed ID: 24388868
[TBL] [Abstract][Full Text] [Related]
23. Comparison between montelukast and tiotropium as add-on therapy to inhaled corticosteroids plus a long-acting β
Hoshino M; Akitsu K; Ohtawa J
J Asthma; 2019 Sep; 56(9):995-1003. PubMed ID: 30212239
[No Abstract] [Full Text] [Related]
24. Differences in the efficacy and safety among inhaled corticosteroids (ICS)/long-acting beta2-agonists (LABA) combinations in the treatment of chronic obstructive pulmonary disease (COPD): Role of ICS.
Latorre M; Novelli F; Vagaggini B; Braido F; Papi A; Sanduzzi A; Santus P; Scichilone N; Paggiaro P
Pulm Pharmacol Ther; 2015 Feb; 30():44-50. PubMed ID: 25445928
[TBL] [Abstract][Full Text] [Related]
25. Inhaled beclometasone dipropionate/formoterol fumarate extrafine fixed combination for the treatment of asthma.
Crisafulli E; Zanini A; Pisi G; Pignatti P; Poli G; Scuri M; Chetta A
Expert Rev Respir Med; 2016; 10(5):481-90. PubMed ID: 26938578
[TBL] [Abstract][Full Text] [Related]
26. Fluticasone/formoterol compared with other ICS/LABAs in asthma: a systematic review.
Venkitakrishnan Md Dnb R; Thomas Md PK; Bansal Md Dnb A; Ghosh Md I; Augustine Dtcd Dnb J; Divya Md R; Cleetus Dtcd Dnb M
J Asthma; 2022 Jun; 59(6):1221-1230. PubMed ID: 33685323
[TBL] [Abstract][Full Text] [Related]
27. Asthma control in patients treated with inhaled corticosteroids and long-acting beta agonists: A population-based analysis in Germany.
Kondla A; Glaab T; Pedersini R; Lommatzsch M
Respir Med; 2016 Sep; 118():58-64. PubMed ID: 27578472
[TBL] [Abstract][Full Text] [Related]
28. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.
Berger WE; Noonan MJ
J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601
[TBL] [Abstract][Full Text] [Related]
29. A retrospective database study comparing treatment outcomes and cost associated with choice of fixed-dose inhaled corticosteroid/long-acting beta-agonists for asthma maintenance treatment in Germany.
Aballéa S; Cure S; Vogelmeier C; Wirén A
Int J Clin Pract; 2008 Dec; 62(12):1870-9. PubMed ID: 18803555
[TBL] [Abstract][Full Text] [Related]
30. Effects of beclomethason/formoterol and budesonide/formoterol fixed combinations on lung function and airway inflammation in patients with mild to moderate asthma--an exploratory study.
Kirsten AM; Watz H; Brindicci C; Piccinno A; Magnussen H
Pulm Pharmacol Ther; 2015 Apr; 31():79-84. PubMed ID: 25194884
[TBL] [Abstract][Full Text] [Related]
31. Overall asthma control: the relationship between current control and future risk.
Bateman ED; Reddel HK; Eriksson G; Peterson S; Ostlund O; Sears MR; Jenkins C; Humbert M; Buhl R; Harrison TW; Quirce S; O'Byrne PM
J Allergy Clin Immunol; 2010 Mar; 125(3):600-8, 608.e1-608.e6. PubMed ID: 20153029
[TBL] [Abstract][Full Text] [Related]
32. Is the patient's baseline inhaled steroid dose a factor for choosing the budesonide/formoterol maintenance and reliever therapy regimen?
Aubier M; Haughney J; Selroos O; van Schayck OC; Ekström T; Ostinelli J; Buhl R
Ther Adv Respir Dis; 2011 Oct; 5(5):289-98. PubMed ID: 21586508
[TBL] [Abstract][Full Text] [Related]
33. Serious Asthma Outcomes and Asthma Exacerbations with Maintenance on Inhaled Corticosteroid (Mometasone Furoate)/Long-Acting Beta Agonist (Formoterol) Combination Compared to Step Down to Mometasone Monotherapy.
Weinstein CLJ; Ryan N; Zhang X; Shekar T; Gates D; Lane SJ; Agache I; Nathan RA;
J Allergy Clin Immunol Pract; 2020 May; 8(5):1634-1644.e1. PubMed ID: 31981733
[TBL] [Abstract][Full Text] [Related]
34. Switching from salmeterol/fluticasone to formoterol/budesonide combinations improves peripheral airway/alveolar inflammation in asthma.
Akamatsu T; Shirai T; Kato M; Yasui H; Hashimoto D; Fujisawa T; Tsuchiya T; Inui N; Suda T; Chida K
Pulm Pharmacol Ther; 2014 Feb; 27(1):52-6. PubMed ID: 23583566
[TBL] [Abstract][Full Text] [Related]
35. Treatment persistence and exacerbations in patients with asthma initiating treatment with inhaled corticosteroids and beta-adrenergic agonists: retrospective cohort study.
Sicras-Mainar A; Gómez Rodríguez B; Traseira-Lugilde S; Fernández-Sánchez T; Velasco Garrido JL
BMJ Open; 2022 Apr; 12(4):e053964. PubMed ID: 35443946
[TBL] [Abstract][Full Text] [Related]
36. Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long-acting beta-agonist inhaler therapy in asthma.
Perrin K; Williams M; Wijesinghe M; James K; Weatherall M; Beasley R
J Allergy Clin Immunol; 2010 Sep; 126(3):505-10. PubMed ID: 20816187
[TBL] [Abstract][Full Text] [Related]
37. Effects on small airway obstruction of long-term treatments with beclomethasone/formoterol hydrofluoroalkane (metered-dose inhaler) versus fluticasone/salmeterol (dry-powder inhaler) in asthma: a preliminary study.
Corda L; Gardenghi GG; Modina D; Montemurro LT; Novali M; Tantucci C
Allergy Asthma Proc; 2011; 32(6):29-34. PubMed ID: 22221427
[TBL] [Abstract][Full Text] [Related]
38. Do inhaled corticosteroid/long-acting beta2-agonist fixed combinations provide superior clinical benefits compared with separate inhalers? A literature reappraisal.
Barnes PJ; Nicolini G; Bizzi A; Spinola M; Singh D
Allergy Asthma Proc; 2012; 33(2):140-4. PubMed ID: 22525390
[TBL] [Abstract][Full Text] [Related]
39. Real-world effects of two inhaled corticosteroid/long-acting β₂-agonist combinations in the treatment of asthma.
Yatera K; Yamasaki K; Nishida C; Noguchi S; Oda K; Akata K; Nagata S; Kawanami Y; Kawanami T; Ishimoto H; Mukae H
J Asthma; 2014 Sep; 51(7):762-8. PubMed ID: 24654703
[TBL] [Abstract][Full Text] [Related]
40. Assessment of anti-inflammatory effect from addition of a long-acting beta-2 agonist to inhaled corticosteroid.
Shimoda T; Obase Y; Kishikawa R; Mukae H; Iwanaga T
Allergy Asthma Proc; 2016 Sep; 37(5):387-93. PubMed ID: 27657522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]